Phibro Animal Health Corporation $PAHC Stock: Keybank National Association OH Boosts Position

Keybank National Association OH raised its holdings in Phibro Animal Health Corporation (NASDAQ:PAHC) by 16.5% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 189,576 shares of the company’s stock after purchasing an additional 26,839 shares during the quarter. Keybank National Association OH’s holdings in Phibro Animal Health were worth $6,775,000 as of its most recent SEC filing.

Several other large investors have also modified their holdings of the business. Renaissance Technologies LLC grew its holdings in shares of Phibro Animal Health by 5.8% during the 1st quarter. Renaissance Technologies LLC now owns 576,735 shares of the company’s stock worth $31,899,000 after purchasing an additional 31,435 shares during the period. Dimensional Fund Advisors LP raised its holdings in Phibro Animal Health by 3.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 507,852 shares of the company’s stock valued at $28,086,000 after buying an additional 15,517 shares during the period. Ranger Investment Management L.P. purchased a new stake in Phibro Animal Health in the 2nd quarter valued at about $9,182,000. Allspring Global Investments Holdings LLC raised its holdings in Phibro Animal Health by 145.5% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 286,172 shares of the company’s stock valued at $15,671,000 after buying an additional 169,628 shares during the period. Finally, Globeflex Capital L P acquired a new position in Phibro Animal Health in the second quarter valued at about $5,942,000. Institutional investors and hedge funds own 99.34% of the company’s stock.

Phibro Animal Health Trading Up 0.9%

NASDAQ PAHC opened at $35.46 on Friday. The firm’s fifty day moving average price is $36.80 and its 200 day moving average price is $40.91. Phibro Animal Health Corporation has a 12 month low of $28.25 and a 12 month high of $60.08. The company has a debt-to-equity ratio of 1.70, a current ratio of 3.20 and a quick ratio of 1.28. The company has a market capitalization of $1.44 billion, a price-to-earnings ratio of 10.75 and a beta of 0.42.

Phibro Animal Health (NASDAQ:PAHC) last announced its quarterly earnings results on Wednesday, November 4th. The company reported $0.79 earnings per share for the quarter, beating analysts’ consensus estimates of $0.78 by $0.01. Phibro Animal Health had a net margin of 6.66% and a return on equity of 35.88%. The firm had revenue of $386.77 million during the quarter, compared to analysts’ expectations of $382.42 million. On average, sell-side analysts expect that Phibro Animal Health Corporation will post 3.48 earnings per share for the current fiscal year.

Phibro Animal Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, December 16th. Stockholders of record on Wednesday, November 25th will be given a dividend of $0.12 per share. The ex-dividend date is Wednesday, November 25th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 1.4%. Phibro Animal Health’s payout ratio is 19.12%.

Wall Street Analyst Weigh In

PAHC has been the topic of several recent analyst reports. Zacks Research lowered shares of Phibro Animal Health from a “strong-buy” rating to a “hold” rating in a report on Tuesday. Weiss Ratings upgraded shares of Phibro Animal Health from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, November 2nd. One investment analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $46.50.

Phibro Animal Health Profile

Phibro Animal Health Corporation develops and markets products for animal health and nutrition. Its portfolio includes vaccines, medicated feed additives, and nutritional specialty products designed to support the health and productivity of livestock and other animals. The company also supplies trace minerals and related products used in animal nutrition and other applications. Its products serve markets including poultry, cattle, swine, and aquaculture, and are sold to customers in the United States and internationally.